Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
SEK 3.42
(-2.29%)
SEK 3.42
(-2.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -23.7 Million | -23.22 Million | -15 Million | -4.06 Million |
| Net Income | -13.88 Million | -19.43 Million | -14.66 Million | -5.55 Million |
| Depreciation & Amortization | - | 1.25 Million | 1 Million | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | 68 Thousand | 148 Thousand | - |
| Change in working capital | -9.82 Million | -5.37 Million | -1.36 Million | 884 Thousand |
| Other non-cash items | - | 279 Thousand | - | - |
| Investing Cash Flow | -2.95 Million | -862 Thousand | -24.39 Million | -26.73 Million |
| Investments in PPE | - | -862 Thousand | -24.39 Million | -23.08 Million |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | -3.64 Million |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -2.95 Million | -862 Thousand | - | - |
| Financing Cash Flow | 33.43 Million | -717 Thousand | 59.58 Million | 43.94 Million |
| Debt repayment | - | -717 Thousand | -14.64 Million | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | 44.94 Million | 43.94 Million |
| Other Financing Activities | 33.43 Million | - | - | - |
| Accounts receivables | - | -11.16 Million | - | - |
| Accounts payables | - | - | - | - |
| Inventory | - | -331 Thousand | -1.77 Million | - |
| Other working capital | -9.82 Million | 6.12 Million | - | - |
| Cash at beginning of period | 8.52 Million | 33.33 Million | 13.14 Million | - |
| Cash at end of period | 15.3 Million | 8.52 Million | 33.33 Million | 13.14 Million |
| Capital Expenditure | - | -862 Thousand | -24.39 Million | -23.08 Million |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 6.77 Million | -24.8 Million | 20.18 Million | 13.14 Million |
| Free Cash Flow | -23.7 Million | -24.08 Million | -39.39 Million | -27.15 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.35 Million | - | - | -3.35 Million | - | -19.43 Million |
| Depreciation & Amortization | - | - | - | - | - | 1.25 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 68 Thousand |
| Change in working capital | -2.22 Million | -1.74 Million | -3.53 Million | -2.32 Million | 701 Thousand | -5.37 Million |
| Other non-cash items | - | -8.43 Million | - | - | - | 279 Thousand |
| Investing Cash Flow | -166 Thousand | 834 Thousand | -1.27 Million | -2.34 Million | -54 Thousand | -862 Thousand |
| Investments in PPE | - | - | - | - | - | -862 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -166 Thousand | 834 Thousand | - | - | - | - |
| Financing Cash Flow | -92 Thousand | 18.36 Million | -229 Thousand | 15.39 Million | -714 Thousand | -717 Thousand |
| Debt repayment | - | - | - | - | - | -717 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -92 Thousand | 18.36 Million | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | -331 Thousand |
| Other working capital | -2.22 Million | -1.74 Million | - | - | - | - |
| Cash at beginning of period | 15.43 Million | 6.41 Million | 15.89 Million | 8.52 Million | 12.92 Million | 33.33 Million |
| Cash at end of period | 15.3 Million | 15.43 Million | 6.41 Million | 15.89 Million | 8.52 Million | 8.52 Million |
| Capital Expenditure | - | - | - | - | - | -862 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -128 Thousand | 9.01 Million | -9.48 Million | 7.36 Million | -4.39 Million | -24.8 Million |
| Free Cash Flow | 130 Thousand | -10.18 Million | -7.97 Million | -5.67 Million | -3.63 Million | -24.08 Million |
688305
VANTI
002720
JINDALSTEL
ANRGF
121600